US Patent 7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
Patent 7446106 was granted and assigned to Smithkline Beecham Limited on November, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+216 characters)
Article
Patent abstract
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07446106 Pyridylfurans and pyrroles as Raf kinase inhibitors US Patent 7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
Infobox
Patent Number
0744610600
Patent Number
744610600
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074461060
Date of Patent
November 4, 2008
0Patent Application Number
104885770
Date Filed
September 5, 2002
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074461060
Date of Patent
November 4, 2008
0Patent Application Number
104885770
Date Filed
September 5, 2002
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07446106
Date of patent
November 4, 2008
Patent application number
10488577
Date Filed
September 5, 2002
Patent primary examiner
Find more entities like US Patent 7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
